Job title: Chief Scientific Officer
Prof. Renfeng Guo, M.D., is a trained immunologist with a broad research background in the areas of cancer immunology, infection, inflammation (ALI and Sepsis), and complement. He has been a faculty member at the University of Michigan since 2001, where he remains an Adjunct Research Associate Professor. He has authored and co-authored over 80 publications in the field of immunological research. One of his notable research achievements was to help understand the roles of C5a/C5aR pathways that contribute to the pathogenesis of bacterial and viral sepsis. As Founder and CSO of InflaRx, Prof. Guo has been leading scientific development at InflaRx since its inception in 2007.
Potential Role of C5a-elicited Inflammation in COVID-19 Pathogenesis 9:30 am
Download the Full Event Guide to find out more Read more
day: Day Two